Patrick Stancombe

This inventor holds 20 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Fusion Proteins. Top assignees: Syntaxin Limited, Allergan, Inc., Health Protection Agency. Active years: 2007-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patrick Stancombe. Retrieved from https://idiyas.com/inventor/patrick-stancombe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 2)

% Patents Active = 55.0

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 6.3

ph-index = 8

Forward Citations = 233(Granted Patents)

Location History:

Oxon, GB (2013)
Abingdon, GB (2013 - 2015)
Salisbury, GB (2007 - 2016)

Company Filing History:

Health Protection Agency

patents

4. 1 out of 27

Ipsen Bioinnovation Limited

patents

5. 1 out of 1

The Health Protection Agency Ipsen Limited

patent

6. 1 out of 28

The Secretary of State for Health

patents

where one patent can have more than one assignee

Years Active: 2007-2016

Loading Chart...

Areas of Expertise:

Fusion Proteins

Recombinant Toxin Fragments

Non-Cytotoxic Proteins

EGF Muteins

Pain Treatment

Biotechnology

Protein Engineering

Therapeutics

Molecular Biology

Biopharmaceuticals

Protein Design

Drug Development

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9243301 - Fusion proteins (2016-01-26),

2. 9072736 - Treatment of pain (2015-07-07),

3. 9006395 - Recombinant toxin fragments (2015-04-14),

4. 8956847 - Fusion proteins (2015-02-17),

5. 8940870 - Fusion proteins (2015-01-27),

6. 8614069 - Non-cytotoxic fusion proteins comprising EGF muteins (2013-12-24),

7. 8454976 - Recombinant toxin fragments (2013-06-04),

8. 8399401 - Fusion proteins (2013-03-19),

9. 8399400 - Fusion proteins (2013-03-19),

10. 8372615 - Fusion proteins (2013-02-12),

11. 8124405 - Fusion proteins (2012-02-28),

12. 8124074 - Fusion proteins (2012-02-28),

13. 8067200 - Fusion proteins (2011-11-29),

14. 8017134 - Recombinant toxin fragments (2011-09-13),

15. 8012491 - Recombinant toxin fragments (2011-09-06),

Title: Patrick Stancombe - Innovative Inventor from Salisbury, GB

Introduction: Patrick Stancombe is a renowned inventor hailing from Salisbury, GB, known for his groundbreaking contributions to various industries.

Latest Patents: Patrick Stancombe holds several patents in the fields of renewable energy, sustainable agriculture, and advanced materials.

Career Highlights: With a career spanning over two decades, Patrick Stancombe has been instrumental in developing cutting-edge technologies that have revolutionized the way we approach environmental challenges.

Collaborations: Throughout his career, Patrick Stancombe has collaborated with leading research institutions, universities, and companies to bring his innovative ideas to life and make a positive impact on society.

Conclusion: Patrick Stancombe's passion for innovation and commitment to creating a sustainable future through his inventions make him a true pioneer in the world of technology.

Profile summary based on public USPTO records.